Using highly variable warfarin dosing to identify patients at risk for adverse events
<p>Abstract</p> <p>Background</p> <p>Patients who receive highly variable doses of warfarin may be at risk for poor anticoagulation control and adverse events. However, we lack a system to identify patients with the highest dose variability. Our objectives were to devel...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://www.thrombosisjournal.com/content/9/1/14 |